Immunome, Inc. (IMNM)
22.82
-0.51
(-2.19%)
USD |
NASDAQ |
May 05, 12:07
Immunome Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 48.07% |
| Scholar Rock Holding Corp. | -- |
| Stoke Therapeutics, Inc. | -4.13K% |
| Nurix Therapeutics, Inc. | -1.39K% |
| Zymeworks, Inc. | -1.64K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.14% |
| Return on Assets | -57.04% |
| Return on Invested Capital | -63.31% |
| Return on Net Operating Assets | -1.40K% |